Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease

被引:87
作者
Mielke, R
Schroder, R
Fink, GR
Kessler, J
Herholz, K
Heiss, WD
机构
[1] MAX PLANCK INST NEUROL RES,D-50931 COLOGNE,GERMANY
[2] UNIV COLOGNE,NEUROL KLIN,W-5000 COLOGNE,GERMANY
[3] UNIV KLIN KOLN,NEUROPATHOL LAB,W-5000 COLOGNE,GERMANY
关键词
Alzheimer's disease; regional cerebral glucose metabolism; semiquantitative neuropathology; neurofibrillary tangles; senile plaques;
D O I
10.1007/s004010050410
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In four patients with an antemortem diagnosis of probable Alzheimer's disease (AD) regional cerebral glucose metabolism (rCMRGl) was studied prospectively by positron emission tomography (PET) and compared with postmortem semiquantitative neuropathology. The interval between the last PET study and autopsy was 1.3+/-0.8 years. In comparison with age-matched controls, the AD patients showed predominant temporoparietal hypometabolism spreading to other cortical and subcortical regions during serial PET scans. All patients had neuropathological findings typical for AD. There was a significant relationship between rCMRGl and density of senile plaques (SP) in one patient (tau(b) = -0.86, P < 0.05). SP were distributed quite homogeneously in all regions examined. Neurofibrillary tangles (NFT) were concentrated focally in the hippocampus-amygdala-entorhinal complex. In the context of widespread developing cortical hypometabolism, the predilection of NFT for involvement in limbic areas suggests a disruption of projection neurons as the pathogenetic process of cortical dysfunction.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 44 条
[31]   CLINICAL DETERIORATION IN PROBABLE ALZHEIMERS-DISEASE CORRELATES WITH PROGRESSIVE METABOLIC IMPAIRMENT OF ASSOCIATION AREAS [J].
MIELKE, R ;
HERHOLZ, K ;
GROND, M ;
KESSLER, J ;
HEISS, WD .
DEMENTIA, 1994, 5 (01) :36-41
[32]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[33]   VALIDATION OF CLINICAL DIAGNOSTIC-CRITERIA FOR ALZHEIMERS-DISEASE [J].
MORRIS, JC ;
MCKEEL, DW ;
FULLING, K ;
TORACK, RM ;
BERG, L .
ANNALS OF NEUROLOGY, 1988, 24 (01) :17-22
[34]   ALZHEIMERS-DISEASE - A CORRELATIVE STUDY [J].
NEARY, D ;
SNOWDEN, JS ;
MANN, DMA ;
BOWEN, DM ;
SIMS, NR ;
NORTHEN, B ;
YATES, PO ;
DAVISON, AN .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (03) :229-237
[35]   AN IMMUNOPEROXIDASE STUDY OF SENILE CEREBRAL AMYLOIDOSIS WITH PATHOGENETIC CONSIDERATIONS [J].
POWERS, JM ;
SCHLAEPFER, WW ;
WILLINGHAM, MC ;
HALL, BJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1981, 40 (06) :592-612
[36]  
REISBERG B, 1982, AM J PSYCHIAT, V139, P1136
[37]   [FLUORODEOXYGLUCOSE-F-18 METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE-UTILIZATION IN MAN [J].
REIVICH, M ;
KUHL, D ;
WOLF, A ;
GREENBERG, J ;
PHELPS, M ;
IDO, T ;
CASELLA, V ;
FOWLER, J ;
HOFFMAN, E ;
ALAVI, A ;
SOM, P ;
SOKOLOFF, L .
CIRCULATION RESEARCH, 1979, 44 (01) :127-137
[38]   [DEOXYGLUCOSE-C-14 METHOD FOR MEASUREMENT OF LOCAL CEREBRAL GLUCOSE-UTILIZATION - THEORY, PROCEDURE, AND NORMAL VALUES IN CONSCIOUS AND ANESTHETIZED ALBINO-RAT [J].
SOKOLOFF, L ;
REIVICH, M ;
KENNEDY, C ;
DESROSIERS, MH ;
PATLAK, CS ;
PETTIGREW, KD ;
SAKURADA, O ;
SHINOHARA, M .
JOURNAL OF NEUROCHEMISTRY, 1977, 28 (05) :897-916
[39]   ACCURACY OF CLINICAL-DIAGNOSIS IN PRIMARY DEGENERATIVE DEMENTIA - CORRELATION WITH NEUROPATHOLOGICAL FINDINGS [J].
SULKAVA, R ;
HALTIA, M ;
PAETAU, A ;
WIKSTROM, J ;
PALO, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (01) :9-13
[40]   PHYSICAL BASIS OF COGNITIVE ALTERATIONS IN ALZHEIMERS-DISEASE - SYNAPSE LOSS IS THE MAJOR CORRELATE OF COGNITIVE IMPAIRMENT [J].
TERRY, RD ;
MASLIAH, E ;
SALMON, DP ;
BUTTERS, N ;
DETERESA, R ;
HILL, R ;
HANSEN, LA ;
KATZMAN, R .
ANNALS OF NEUROLOGY, 1991, 30 (04) :572-580